Anti-Fibrotic Drug Discovery 2020
DOI: 10.1039/9781788015783-00211
|View full text |Cite
|
Sign up to set email alerts
|

Emerging Role of CXCR4 in Fibrosis

Abstract: Recent evidence has shown that the chemokine receptor CXCR4 and its natural chemokine ligand CXCL12 promote pro-inflammatory responses in a variety of situations and this axis has emerged as a central player in tissue fibrosis. Although its role as a co-receptor for human immunodeficiency virus (HIV) and a key player in various cancers has been well established, the role of CXCR4 in various types of fibrosis has emerged only recently. This review will explore the involvement of CXCR4 in the development of fibr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 140 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?